Pharmaceuticals Saudi Arabia

Saudi Arabia Allergy Immunotherapy Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Saudi Arabia Allergy Immunotherapy Market Industry Trends and Forecast to 2034: Segmented by (Type, Allergen, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Saudi Arabia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $43.0 Mn Placeholder estimate
Estimate 2025 $47.2 Mn 2% of the global market
Projected 2034 $110.4 Mn 133.9% Adds $63.2 Mn over 9 forecast years
CAGR 2025–2034 9.9% Faster than 54% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Saudi Arabia is 2.02% of the global market.
  • In Middle East, the largest is Saudi Arabia (this report) at $47.2 Mn.
  • Fastest growing: Saudi Arabia (this report) at 9.9% a year.
  • Saudi Arabia ranks 1st of 2 by size in Middle East.

Market size projection

Saudi Arabia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$63.2 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Allergy Immunotherapy Market market size by year, Saudi Arabia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $43.0 Mn — —
2025 (base) $47.2 Mn +$4.3 Mn —
2026 (forecast) $51.9 Mn +$4.7 Mn +9.9%
2027 (forecast) $57.0 Mn +$5.1 Mn +20.8%
2028 (forecast) $62.7 Mn +$5.6 Mn +32.7%
2029 (forecast) $68.9 Mn +$6.2 Mn +45.9%
2030 (forecast) $75.7 Mn +$6.8 Mn +60.3%
2031 (forecast) $83.2 Mn +$7.5 Mn +76.2%
2032 (forecast) $91.4 Mn +$8.2 Mn +93.6%
2033 (forecast) $100.5 Mn +$9.1 Mn +112.8%
2034 (forecast) $110.4 Mn +$9.9 Mn +133.9%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.33 Bn
  2. US $1.04 Bn
  3. North America $1.01 Bn
  4. Europe $495.0 Mn
  5. APAC $465.4 Mn
  6. China $199.5 Mn
  7. Canada $162.4 Mn
  8. Japan $136.4 Mn
  9. Latin America $113.9 Mn
  10. Middle East $83.3 Mn
  11. Germany $74.3 Mn
  12. France $67.2 Mn
  13. UK $59.9 Mn
  14. Italy $53.2 Mn
  15. Spain $50.5 Mn
  16. Brazil $51.4 Mn
  17. Ecuador $50.0 Mn
  18. Saudi Arabia (this report) $47.2 Mn
  19. India $41.0 Mn
  20. Africa $33.5 Mn
  21. Mexico $31.0 Mn
  22. Australia $28.9 Mn
  23. Russia $21.4 Mn
  24. New Zealand $21.1 Mn
  25. South Africa $14.5 Mn
  26. UAE $10.9 Mn
  27. Egypt $6.4 Mn
  28. Philippines $5.3 Mn
  29. Malaysia $3.7 Mn
  30. Hong Kong $3.6 Mn
  31. Thailand $3.2 Mn
  32. Singapore $2.6 Mn
  33. Kenya $1.8 Mn

Report snapshot

Saudi Arabia Allergy Immunotherapy Market Analysis at a glance
Market size, 2025$47.2 Mn placeholder estimate
Forecast, 2034$110.4 Mn placeholder estimate
Growth (CAGR), 2025–20349.9% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsType, allergen and end user (see all)
Key playersALK-Abello, Stallergenes Greer, HAL Allergy, Allergy Therapeutics, Aimmune (Nestle) (see all)
Regulator in Saudi ArabiaSFDASource: Saudi Food and Drug Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Saudi Arabia Allergy Immunotherapy Market Analysis Executive Summary

Allergy immunotherapy gradually trains the immune system to tolerate allergens, using shots, tablets or drops.

Key segments of the allergy Immunotherapy market include type (Subcutaneous Immunotherapy, Sublingual Tablets and Sublingual Drops) and allergen (Pollen, Dust Mites and Food).

Bar chart: Saudi Arabia Allergy Immunotherapy market size, 2024–2034, placeholder estimates. $43.0 Mn in 2024, $47.2 Mn in 2025 and $110.4 Mn in 2034, 9.9% CAGR.
Saudi Arabia Allergy Immunotherapy market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Saudi Arabia Allergy Immunotherapy Market Dynamics

Market Growth Drivers

More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the allergy Immunotherapy market. Biosimilars are widening access.

Opportunity

New targets, oral drugs that replace injections and cell therapies for autoimmune disease give the allergy Immunotherapy market room to grow.

Market Restraints

High prices, infection risks with immune-suppressing drugs, patent expiries and the need for long-term treatment hold back the allergy Immunotherapy market.

Competitive Landscape for Allergy Immunotherapy Market in Saudi Arabia

The allergy Immunotherapy market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Allergy Immunotherapy Market in Saudi Arabia

Allergy Immunotherapy in Saudi Arabia: rules and payment

The Saudi Food and Drug Authority (SFDA) registers medicines before sale.⁠[1] Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI).⁠[2]

[1] Saudi Food and Drug Authority. Checked 14 Nov 2026.

[2] Council of Health Insurance. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for allergy Immunotherapy. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Saudi Arabia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Allergy Immunotherapy right now, from free public sources.

Latest research 132 papers since 2021 (worldwide)

  1. Editorial: Allergens and allergic sensitization in Asia and the tropics-volume II. Frontiers in allergy, 2026
  2. Immunization with Virus-Like Particles Displaying Ara h 2‑Derived Peptides to Mitigate Peanut Allergy. ACS nano medicine, 2026
  3. Mannan-based oral nanovaccine rebalances intestinal immunity against food allergy. Science bulletin, 2026
  4. The Food Allergy-Eosinophilic Esophagitis Continuum: Implications for Food Allergy Immunotherapy. The journal of allergy and clinical immunology. In practice, 2026
  5. Early Allergen Introduction in Delaware: A Model to Address Healthcare Disparities and Population Healthcare Costs. Cureus, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Allergy Immunotherapy in context

Saudi Arabia compared

  • Health spending per person: 1,825 US$ per person (2023). World: 1,317 US$ per person (2023). 2nd highest of the 9 countries we cover in Middle East.[1]
  • Doctors: 3.41 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). Highest of the 9 countries we cover in Middle East.[2]
  • People aged 65 and over: 3.1% of people (2025). World: 10.4% of people (2025). 6th highest of the 9 countries we cover in Middle East.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Allergy Immunotherapy market in Saudi Arabia?
Placeholder estimate: about $47.2 Mn in 2025, rising to about $110.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Allergy Immunotherapy market in Saudi Arabia growing?
Placeholder estimate: about 9.9% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Allergy Immunotherapy market report cover?
The report splits the market by type (Subcutaneous Immunotherapy, Sublingual Tablets, Sublingual Drops, Oral Food Immunotherapy), allergen (Pollen, Dust Mites, Food, Insect Venom) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Allergy Immunotherapy market?
Key players include ALK-Abello, Stallergenes Greer, HAL Allergy, Allergy Therapeutics and Aimmune (Nestle).
What is driving the Allergy Immunotherapy market?
More people diagnosed with immune diseases, strong results from biologics and oral targeted drugs, and earlier treatment are driving the allergy Immunotherapy market. Biosimilars are widening access.
Who regulates Allergy Immunotherapy in Saudi Arabia?
The Saudi Food and Drug Authority (SFDA) registers medicines before sale. Source: Saudi Food and Drug Authority. Checked 14 Nov 2026.
How is healthcare paid for in Saudi Arabia?
Citizens get free public care through the Ministry of Health, while most expatriate workers must have private health insurance, regulated by the Council of Health Insurance (CHI). Source: Council of Health Insurance. Checked 14 Nov 2026.
How much research is published on Allergy Immunotherapy?
PubMed lists 132 papers on Allergy Immunotherapy added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Allergy Immunotherapy in Saudi Arabia? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Patient Support Programmes: Helping Patients Stay on TreatmentWHO says only about half of patients in developed countries take long-term medicines as prescribed. Patient… Biologic Safety Testing: The Quiet Backbone of Drug MakingEvery vaccine, antibody and cell therapy must be tested for sterility, purity and viruses before it reaches… Cell-Based Immunotherapy: Promise and PriceThe first CAR-T cell therapy was approved in the US in August 2017. These living drugs can work when other…
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Saudi Arabia

See all
Same topic, other categories

Related on allergies and biologics and biosimilars

See the topic